Skip to main content
. 2015 Aug 19;89(21):10860–10867. doi: 10.1128/JVI.01627-15

FIG 4.

FIG 4

Therapeutic effects of IFN-β on CVA16-infected TRIF-deficient mice. Fourteen-day-old TRIF-deficient C57BL/6 mice were infected i.p. with 1.5 × 103 PFU CVA16 and then injected i.p. with 3 × 104 units of IFN-β per mouse per day (n = 11) or saline (n = 9) on days 1, 2, and 3 postinfection. The clinical scores (A) and survival rates (B) are shown.